SH Yuliani - Int. J. Appl. Pharm, 2021 - academia.edu
In just a matter of months, SARS-CoV-2 had spread around the world. Scientists collaborate to solve the problem. The development of antiviral drugs is a challenge in itself due to the …
O Kapuy, T Korcsmáros - Plos one, 2022 - journals.plos.org
The COVID-19 pandemic caused by SARS-CoV-2 has resulted in an urgent need for identifying potential therapeutic drugs. In the first half of 2020 tropic antimalarial drugs, such …
M Farzanehpour, A Shahriary, R Dorostkar… - Journal of Applied …, 2023 - biotechrep.ir
Vaccination is the most effective method to prevent dangerous infectious diseases and save lives. The expansion of human communication, the rapid spread of emerging infections …
Background The coronavirus disease 2019 pandemic has disrupted the delivery of safe surgical care worldwide. One specific aspect of global surgical care that has been severely …
C Mura, S Preissner, R Preissner… - Frontiers in …, 2021 - frontiersin.org
This Perspective examines a recent surge of information regarding the potential benefits of acid-suppression drugs in the context of COVID-19, with a particular eye on the great …
HY Liao, HY Huang, X Chen, CW Cheng, SW Wang… - bioRxiv, 2021 - biorxiv.org
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in more than 167 million confirmed …
Animal-derived venoms are complex mixtures of toxins triggering important biological effects during envenomings. Although venom-derived toxins are known for their potential of causing …
Çin'de 2019 yılının sonunda ortaya çıkan yeni Koranavirüs türü SARS-CoV-2 olarak adlandırılmış ve hastalığının ismine de Yeni Koronavirüs Hastalığı (COVID-19) adı …
H Noh, S Yoon, SH Kim, J Kim, JS Seo, JJ Kim… - Pulmonary …, 2023 - Elsevier
Throughout the recent COVID-19 pandemic, South Korea led national efforts to develop vaccines and therapeutics for SARS-CoV-2. The project proceeded as follows: 1) evaluation …